Pre-earnings options volume in Prokidney (PROK) Corp is normal with calls leading puts 12:1. Implied volatility suggests the market is anticipating a move near 13.0%, or 35c, after results are released. Median move over the past eight quarters is 2.6%.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROK:
- Prokidney’s REACT Study: A Promising Step for Kidney Disease Treatment
- Largest borrow rate increases among liquid names
- ProKidney’s Hold Rating: Balancing FDA Alignment and Extended Approval Timeline
- ProKidney’s Clinical Trials and Regulatory Developments Lead to Hold Rating Amid Uncertainty
- ProKidney’s Strategic FDA Alignment and Promising Clinical Data Drive Buy Rating